SiSi. Книга для тех, у кого есть, будет или когда-то была грудь. Кристи Фанк

Leffers et al., “Oestrogenic Potencies of Zeranol, Oestradiol, Diethylstilboestrol, Bisphenol-A and Genistein: Implications for Exposure Assessment of Potential Endocrine Disrupters,” Human Reproduction 16, no. 5 (2001): 1037–1045.

      206

      W. Ye et al., “In Vitro Transformation of MCF-10A Cells by Sera Harvested from Heifers Two Months Post-Zeranol Implantation,” International Journal of Oncology 38, no. 4 (2011b): 985–992; R. Khosrokhavar et al., “Effects of Zearalenone and κ-zearalenol in Comparison with Raloxifene on T47D Cells,” Toxicology Mechanisms and Methods 19, no. 3 (2009): 246–250.

      207

      E. V. Bandera et al., “Urinary Mycoestrogens, Body Size and Breast Development in New Jersey Girls,” Science of the Total Environment 409, no. 24 (2011): 5221–5227.

      208

      F. Massart and G. Saggese, “Oestrogenic Mycotoxin Exposures and Precocious Pubertal Development,” International Journal of Andrology 33, no. 2 (2010): 369–376.

      209

      E. Linos et al., “Red Meat Consumption During Adolescence among Premenopausal Women and Risk of Breast Cancer,” Cancer Epidemiology and Prevention Biomarkers 17, no. 8 (2008): 2146–2151.

      210

      M. S. Farvid et al., “Premenopausal Dietary Fat in Relation to Pre- and Postmenopausal Breast Cancer,” Breast Cancer Research and Treatment 145, no. 1 (2014): 255.

      211

      J. Niu et al., “The Association between Leptin Level and Breast Cancer: A Metaanalysis.” PloS One 8, no. 6 (2013): e67349.

      212

      P. Xu et al., “Zeranol Enhances Leptin-Induced Proliferation in Primary Cultured Human Breast Cancer Epithelial Cells,” Molecular Medicine Reports 3, no. 5 (2010): 795–800.

      213

      A. C. Vergnaud et al., “Meat Consumption and Prospective Weight Change in Participants of the EPIC-PANACEA Study,” American Journal of Clinical Nutrition 92, no. 2 (2010): 398–407.

      214

      C. P. Velloso, “Regulation of Muscle Mass by Growth Hormone and IGF-1,” British Journal of Pharmacology 154 (2008): 557–568, doi:10.1038/bjp.2008.153; M. LlorensMartin, I. Torres-Aleman, and J. L. Trejo, “Mechanisms Mediating Brain Plasticity: IGF1 and Adult Hippocampal Neurogenesis,” The Neuroscientist 15 (2009): 134–148, doi:10.1177/1073858408331371.

      215

      S. Y. Yang et al., “Growth Factors and Their Receptors in Cancer Metastases,” Frontiers in Bioscience (Landmark Edition) 16 (2011): 531–538.

      216

      M. E. Levine et al., “Low Protein Intake Is Associated with a Major Reduction in IGF-1, Cancer, and Overall Mortality in the 65 and Younger but not Older Population,” Cell Metabolism 19, no. 3 (2014): 407–417.

      217

      M. Leslie, “Growth Defect Blocks Cancer and Diabetes,” Science 331, no. 6019 (2011): 837.

      218

      J. Guevara-Aguirre et al., “Growth Hormone Receptor Deficiency Is Associated with a Major Reduction in Pro-aging Signaling, Cancer, and Diabetes in Humans,” Science Translational Medicine 16, no. 3 (February 2011): 70ra13.

      219

      P. F. Christopoulos, P. Msaouel, and M. Koutsilieris, “The Role of the Insulin-Like Growth Factor-1 System in Breast Cancer,” Molecular Cancer 14, no. 1 (2015): 43; S. Sarkissyan et al., “IGF-1 Regulates Cyr61 Induced Breast Cancer Cell Proliferation and Invasion,” PloS One 9, no. 7 (2014): e103534.

      220

      Hormones, the Endogenous, and Breast Cancer Collaborative Group, “Insulin-Like Growth Factor 1 (IGF1), IGF Binding Protein 3 (IGFBP3), and Breast Cancer Risk: Pooled Individual Data Analysis of 17 Prospective Studies,” The Lancet Oncology 11, no. 6 (2010): 530–542.

      221

      R. J. Barnard et al., “Effects of a Low-Fat, High-Fiber Diet and Exercise Program on Breast Cancer Risk Factors In Vivo and Tumor Cell Growth and Apoptosis In Vitro,” Nutrition and Cancer 55, no. 1 (2006): 28–34.

      222

      R. J. Barnard et al., “A Low-Fat Diet and/or Strenuous Exercise Alters the IGF Axis In Vivo and Reduces Prostate Tumor Cell Growth In Vitro,” The Prostate 56, no. 3 (2003): 201–206.

      223

      N. E. Allen et al., “The Associations of Diet with Serum Insulin-Like Growth Factor 1 and Its Main Binding Proteins in 292 Women Meat-eaters, Vegetarians, and Vegans,” Cancer Epidemiology and Prevention Biomarkers 11, no. 11 (2002): 1441–1448.

      224

      S. E. Steck et al., “Cooked Meat and Risk of Breast Cancer: Lifetime versus Recent Dietary Intake,” Epidemiology 18, no. 3 (May 2007): 373–382.

      225

      R. Zaidi, S. Kumar, and P. R. Rawat, “Rapid Detection and Quantification of Dietary Mutagens in Food Using Mass Spectrometry and Ultra Performance Liquid Chromatography,” Food Chemistry 135, no. 4 (2012): 2897–2903.

      226

      H. P. Thiebaud et al., “Airborne Mutagens Produced by Frying Beef, Pork and a Soy-based Food,” Food and Chemical Toxicology 33, no. 10 (1995): 821–828.

      227

      W. Zheng et al., “Well-Done Meat Intake and the Risk of Breast Cancer,” Journal of the National Cancer Institute 90, no. 22 (November 1998): 1724–1729.

      228

      S. N. Lauber, S. Ali, and N. J. Gooderham, “The Cooked Food Derived Carcinogen 2-amino-1-methyl-6-phenylimidazo [4, 5-b] Pyridine Is a Potent Oestrogen: A Mechanistic Basis for Its Tissue-Specific Carcinogenicity,” Carcinogenesis 25, no. 12 (2004): 2509–2517.

      229

      L. S. DeBruin, P. A. Martos, and P. D. Josephy, “Detection of PhIP (2-amino-1-methyl-6-phenylimidazo [4, 5-b] Pyridine) in the Milk of Healthy Women,” Chemical Research in Toxicology 14, no. 11 (2001): 1523–1528.

      230

      R. D. Holland et al., “Formation of a Mutagenic Heterocyclic Aromatic Amine from Creatinine in Urine of Meat Eaters and Vegetarians,” Chemical Research in Toxicology 18, no. 3 (2005): 579–590.

      231

      S. Murray et al., “Effect of Cruciferous Vegetable Consumption on Heterocyclic Aromatic Amine Metabolism in Man,” Carcinogenesis 22, no. 9 (2001): 1413–1420.

      232

      H. A. J. Schut and R. Yao, “Tea as a Potential Chemopreventive Agent in PhIP Carcinogenesis: Effects of Green Tea and Black Tea on PhIP-DNA Adduct Formation in Female F-344 Rats,” Nutrition and Cancer 36, no. 1 (2000): 52–58.

      233

      T.